Urogen Pharma Ltd (URGN)

Financing Cash Flow

$105.29M

TTM · Period ending: · USD

URGN logo

URGN Financing Cash Flow

Latest reported$105.29M
URGN TTM Cash from Financing (-$9.00K → $105.29M)
High-resolution chart · PNG

URGN financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Urogen Pharma Ltd Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
105,292,000
105,088,000
39,918,000
8,673,000
40,007,000
139,996,000
194,619,000
194,588,000
271,059,000
170,917,000
116,931,000
142,259,000
26,696,865
26,476,865
96,547,865
71,147,865
70,465,000
143,057,000
72,319,000
72,429,000
72,658,000
16,441,000
16,527,000
16,694,000
17,759,000
1,834,000
165,250,000
167,205,000
166,065,000
165,671,000
66,421,000
64,165,000
63,780,000
125,949,000
61,585,000
61,572,000
62,349,000
12,000
-9,000
18,038,000
17,790,000
22,138,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.